Selective estrogen receptor modulator effects in the rat brain

Wenxia Zhou, Nina Koldzic-Zivanovic, Charlotte H. Clarke, René De Beun, Karsten Wassermann, Paul S. Bury, Kathryn Cunningham, Mary L. Thomas

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

The effects in the brain of selective estrogen receptor modulators (SERMs) such as tamoxifen and raloxifene have not yet been fully elucidated. Based upon the hypothesis that serotonin (5-HT)-steroid hormone interactions are important in mood regulation, we have compared six SERMs (tamoxifen, raloxifene, levormeloxifene, NNC 45-0781, NNC 45-0320, NNC 45-1506) with 17β-estradiol (E2) in terms of their ability to regulate mRNA levels of estrogen receptor (ER)α, ERβ, 5-HT1A receptor, and 5-HT reuptake transporter (SERT) in the midbrain, amygdala, and hypothalamus of ovariectomized (OVX) rats. Female rats (n = 6/group, 8 groups total) were OVX and allowed to recover for 2 weeks. During the third post-OVX week, rats were injected subcutaneously with E2 (0.1 mg/kg) or one of the SERMs (5 mg/kg) once per day for 7 days. Twenty-four hours after the last injection, tissue was collected for the determination of mRNA levels by ribonuclease protection assay (RPA). E2 treatment significantly decreased mRNA levels for ERα, ERβ, and SERT in midbrain and ERα in hypothalamus. Tamoxifen increased ERβ mRNA levels in hypothalamus, while raloxifene increased ERβ mRNA levels in amygdala. NNC 45-0320 decreased ERα mRNA in hypothalamus and decreased ERβ mRNA in amygdala. These results suggest that while SERMs are not full estrogen receptor agonists in the brain, the agonist/antagonist profiles for individual SERMs may differ among brain areas. This raises the possibility of developing new SERMs for selective functions in specific brain areas.

Original languageEnglish (US)
Pages (from-to)24-33
Number of pages10
JournalNeuroendocrinology
Volume75
Issue number1
DOIs
StatePublished - 2002

Fingerprint

Selective Estrogen Receptor Modulators
Estrogen Receptors
Brain
Messenger RNA
Hypothalamus
Tamoxifen
Amygdala
Serotonin
Mesencephalon
Receptor, Serotonin, 5-HT1A
Aptitude
Ribonucleases
Estradiol
Estrogens
Steroids
Hormones
Injections

Keywords

  • Amygdala
  • Estrogen receptor modulators
  • Gonadal steroid receptors
  • Gonadal steroids
  • Midbrain
  • Serotonin
  • Serotonin reuptake transporter

ASJC Scopus subject areas

  • Endocrinology
  • Neuroscience(all)

Cite this

Zhou, W., Koldzic-Zivanovic, N., Clarke, C. H., De Beun, R., Wassermann, K., Bury, P. S., ... Thomas, M. L. (2002). Selective estrogen receptor modulator effects in the rat brain. Neuroendocrinology, 75(1), 24-33. https://doi.org/10.1159/000048218

Selective estrogen receptor modulator effects in the rat brain. / Zhou, Wenxia; Koldzic-Zivanovic, Nina; Clarke, Charlotte H.; De Beun, René; Wassermann, Karsten; Bury, Paul S.; Cunningham, Kathryn; Thomas, Mary L.

In: Neuroendocrinology, Vol. 75, No. 1, 2002, p. 24-33.

Research output: Contribution to journalArticle

Zhou, W, Koldzic-Zivanovic, N, Clarke, CH, De Beun, R, Wassermann, K, Bury, PS, Cunningham, K & Thomas, ML 2002, 'Selective estrogen receptor modulator effects in the rat brain', Neuroendocrinology, vol. 75, no. 1, pp. 24-33. https://doi.org/10.1159/000048218
Zhou W, Koldzic-Zivanovic N, Clarke CH, De Beun R, Wassermann K, Bury PS et al. Selective estrogen receptor modulator effects in the rat brain. Neuroendocrinology. 2002;75(1):24-33. https://doi.org/10.1159/000048218
Zhou, Wenxia ; Koldzic-Zivanovic, Nina ; Clarke, Charlotte H. ; De Beun, René ; Wassermann, Karsten ; Bury, Paul S. ; Cunningham, Kathryn ; Thomas, Mary L. / Selective estrogen receptor modulator effects in the rat brain. In: Neuroendocrinology. 2002 ; Vol. 75, No. 1. pp. 24-33.
@article{a555a1b622404d22a8755c883e393cb3,
title = "Selective estrogen receptor modulator effects in the rat brain",
abstract = "The effects in the brain of selective estrogen receptor modulators (SERMs) such as tamoxifen and raloxifene have not yet been fully elucidated. Based upon the hypothesis that serotonin (5-HT)-steroid hormone interactions are important in mood regulation, we have compared six SERMs (tamoxifen, raloxifene, levormeloxifene, NNC 45-0781, NNC 45-0320, NNC 45-1506) with 17β-estradiol (E2) in terms of their ability to regulate mRNA levels of estrogen receptor (ER)α, ERβ, 5-HT1A receptor, and 5-HT reuptake transporter (SERT) in the midbrain, amygdala, and hypothalamus of ovariectomized (OVX) rats. Female rats (n = 6/group, 8 groups total) were OVX and allowed to recover for 2 weeks. During the third post-OVX week, rats were injected subcutaneously with E2 (0.1 mg/kg) or one of the SERMs (5 mg/kg) once per day for 7 days. Twenty-four hours after the last injection, tissue was collected for the determination of mRNA levels by ribonuclease protection assay (RPA). E2 treatment significantly decreased mRNA levels for ERα, ERβ, and SERT in midbrain and ERα in hypothalamus. Tamoxifen increased ERβ mRNA levels in hypothalamus, while raloxifene increased ERβ mRNA levels in amygdala. NNC 45-0320 decreased ERα mRNA in hypothalamus and decreased ERβ mRNA in amygdala. These results suggest that while SERMs are not full estrogen receptor agonists in the brain, the agonist/antagonist profiles for individual SERMs may differ among brain areas. This raises the possibility of developing new SERMs for selective functions in specific brain areas.",
keywords = "Amygdala, Estrogen receptor modulators, Gonadal steroid receptors, Gonadal steroids, Midbrain, Serotonin, Serotonin reuptake transporter",
author = "Wenxia Zhou and Nina Koldzic-Zivanovic and Clarke, {Charlotte H.} and {De Beun}, Ren{\'e} and Karsten Wassermann and Bury, {Paul S.} and Kathryn Cunningham and Thomas, {Mary L.}",
year = "2002",
doi = "10.1159/000048218",
language = "English (US)",
volume = "75",
pages = "24--33",
journal = "Neuroendocrinology",
issn = "0028-3835",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Selective estrogen receptor modulator effects in the rat brain

AU - Zhou, Wenxia

AU - Koldzic-Zivanovic, Nina

AU - Clarke, Charlotte H.

AU - De Beun, René

AU - Wassermann, Karsten

AU - Bury, Paul S.

AU - Cunningham, Kathryn

AU - Thomas, Mary L.

PY - 2002

Y1 - 2002

N2 - The effects in the brain of selective estrogen receptor modulators (SERMs) such as tamoxifen and raloxifene have not yet been fully elucidated. Based upon the hypothesis that serotonin (5-HT)-steroid hormone interactions are important in mood regulation, we have compared six SERMs (tamoxifen, raloxifene, levormeloxifene, NNC 45-0781, NNC 45-0320, NNC 45-1506) with 17β-estradiol (E2) in terms of their ability to regulate mRNA levels of estrogen receptor (ER)α, ERβ, 5-HT1A receptor, and 5-HT reuptake transporter (SERT) in the midbrain, amygdala, and hypothalamus of ovariectomized (OVX) rats. Female rats (n = 6/group, 8 groups total) were OVX and allowed to recover for 2 weeks. During the third post-OVX week, rats were injected subcutaneously with E2 (0.1 mg/kg) or one of the SERMs (5 mg/kg) once per day for 7 days. Twenty-four hours after the last injection, tissue was collected for the determination of mRNA levels by ribonuclease protection assay (RPA). E2 treatment significantly decreased mRNA levels for ERα, ERβ, and SERT in midbrain and ERα in hypothalamus. Tamoxifen increased ERβ mRNA levels in hypothalamus, while raloxifene increased ERβ mRNA levels in amygdala. NNC 45-0320 decreased ERα mRNA in hypothalamus and decreased ERβ mRNA in amygdala. These results suggest that while SERMs are not full estrogen receptor agonists in the brain, the agonist/antagonist profiles for individual SERMs may differ among brain areas. This raises the possibility of developing new SERMs for selective functions in specific brain areas.

AB - The effects in the brain of selective estrogen receptor modulators (SERMs) such as tamoxifen and raloxifene have not yet been fully elucidated. Based upon the hypothesis that serotonin (5-HT)-steroid hormone interactions are important in mood regulation, we have compared six SERMs (tamoxifen, raloxifene, levormeloxifene, NNC 45-0781, NNC 45-0320, NNC 45-1506) with 17β-estradiol (E2) in terms of their ability to regulate mRNA levels of estrogen receptor (ER)α, ERβ, 5-HT1A receptor, and 5-HT reuptake transporter (SERT) in the midbrain, amygdala, and hypothalamus of ovariectomized (OVX) rats. Female rats (n = 6/group, 8 groups total) were OVX and allowed to recover for 2 weeks. During the third post-OVX week, rats were injected subcutaneously with E2 (0.1 mg/kg) or one of the SERMs (5 mg/kg) once per day for 7 days. Twenty-four hours after the last injection, tissue was collected for the determination of mRNA levels by ribonuclease protection assay (RPA). E2 treatment significantly decreased mRNA levels for ERα, ERβ, and SERT in midbrain and ERα in hypothalamus. Tamoxifen increased ERβ mRNA levels in hypothalamus, while raloxifene increased ERβ mRNA levels in amygdala. NNC 45-0320 decreased ERα mRNA in hypothalamus and decreased ERβ mRNA in amygdala. These results suggest that while SERMs are not full estrogen receptor agonists in the brain, the agonist/antagonist profiles for individual SERMs may differ among brain areas. This raises the possibility of developing new SERMs for selective functions in specific brain areas.

KW - Amygdala

KW - Estrogen receptor modulators

KW - Gonadal steroid receptors

KW - Gonadal steroids

KW - Midbrain

KW - Serotonin

KW - Serotonin reuptake transporter

UR - http://www.scopus.com/inward/record.url?scp=0036159571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036159571&partnerID=8YFLogxK

U2 - 10.1159/000048218

DO - 10.1159/000048218

M3 - Article

VL - 75

SP - 24

EP - 33

JO - Neuroendocrinology

JF - Neuroendocrinology

SN - 0028-3835

IS - 1

ER -